Open navigation
Search

Life Sciences & Healthcare

Law Firm in the Netherlands specialised in Life Sciences & Healthcare

Latest

  • Legal Update Netherlands
    How the EU Pharma Package will reshape orphan drug regulation
    28 Jul 2026 8 min read
  • Legal Update Netherlands
    The extension of the Bolar exemption in the EU Pharma Package
    21 Jul 2026 8 min read
  • Legal Update Netherlands
    Stability as strategy: The UK’s regulatory position in the wake of the EU Pharmaceutical Package
    15 Jul 2026 7 min read
  • Legal Update Netherlands
    UK Clinical Trial Transparency and Patent Strategy
    13 Jul 2026 12 min read
  • Legal Update Netherlands
    T 655/24 - credibility test for improved technical effect applied to determine inventive step for a single amino acid change following G 2/21
    02 Jul 2026 11 min read
  • Legal Update Netherlands
    ICC Rules 2026: Key Reforms in Context
    09 Jun 2026 11 min read
  • Legal Update Netherlands
    EU AI Act Developments: Key Political Agreement on the Digital Omnibus on AI, Implementation Timeline and Transparency Consultation
    13 May 2026 4 min read

4 specialist practice areas in Life Sciences & Healthcare

E-Health Medical Devices and Diagnostics Novel Food (incl. Cannabis/CBD) Pharmaceuticals

Our dedicated Life Sciences & Healthcare team specialises in advising clients in the pharmaceutical, medical devices, cosmetics, novel food and agriculture industry. ​

We have extensive experience in serving our clients, who represent 80% of the leading industry players. Because many of us have in-house experience, we understand your unique challenges and needs and have the ability to provide you with hands-on commercial advice.​

Our team operates across all relevant legal disciplines involved in supporting this sector. This includes industry specific regulatory and compliance work, intellectual property matters and competition law advice. We also advise on commercial, data privacy, employment, real estate and corporate matters. Our expertise allows us to meet both local and international business needs of our clients.

CMS Netherlands rankings

Band 2
Chambers Europe, 2026
Tier 2
Legal 500 EMEA, 2026

Further reading

  • Subscribe to Life Sciences & Healthcare topics

    Stay up-to-date with our client services.

  • CMS Life Sciences & Healthcare Global Brochure

    Brochures

Our specialist practice areas

E-Health Medical Devices and Diagnostics Novel Food (incl. Cannabis/CBD) Pharmaceuticals

Legal experts for Life Sciences & Healthcare

See all experts
Filter
Ellen Gielen
PARTNER
Ellen Gielen
Advocaat | Co-head of Life Sciences & Healthcare, Netherlands
NETHERLANDS, AMSTERDAM
LIFE SCIENCES & HEALTHCARE
PHARMACEUTICALS
+1 MORE
Contact
Gertie Lintjens
OF COUNSEL
Gertie Lintjens
Advocaat | Co-head of Life Sciences & Healthcare, Netherlands
NETHERLANDS, AMSTERDAM
LIFE SCIENCES & HEALTHCARE
PHARMACEUTICALS
Contact
Jeroen Boelens
PARTNER
Jeroen Boelens
Advocaat
NETHERLANDS, AMSTERDAM
INTELLECTUAL PROPERTY
LIFE SCIENCES & HEALTHCARE
+2 MORE
Contact
Pieter Duijvenvoorde
PARTNER
Pieter van Duijvenvoorde
Advocaat | Head of Corporate/M&A, Netherlands
NETHERLANDS, AMSTERDAM
CORPORATE/M&A
MERGERS & ACQUISITIONS
+3 MORE
Contact
Edmon Oude Elferink
PARTNER
Edmon Oude Elferink
Advocaat
NETHERLANDS, AMSTERDAM|BELGIUM, BRUSSELS
ANTITRUST, COMPETITION & TRADE
REGULATORY
+5 MORE
Contact
Awards & Recognitions
01 –
  • Quote
    "CMS offers in-depth knowledge of the pharmaceutical industry and has a great network with key stakeholders in the industry, which leads to a lot of useful information."
    Chambers Europe, 2025
  • Quote
    "I find CMS to be very helpful. I enjoy working with the team and it provides us with good guidance."
    Chambers Europe, 2025
  • Quote
    "Good and timely follow up, very collaborative and good overall communication."
    The Legal 500 EMEA, 2024
  • Quote
    "CMS’ team offer a deep understanding of the legal specificities of the medical devices industry."
    The Legal 500 EMEA, 2024
  • Quote
    "Knowledgeable about our market environment, very pragmatic and able to translate legal means to business outcomes, easy to work with."
    The Legal 500 EMEA, 2024
  • Quote
    "Our contacts at CMS NL differ from many other lawyers in that they deliver practically usable results. They point out potential risks, but at the same time commit to an outcome and don’t leave us guessing. After the consultation, we are definitely smarter and know our options."
    The Legal 500 EMEA, 2024
  • Quote
    "CMS is able to effectively structure and handle complex legal matters."
    Chambers Europe, 2024
  • Quote
    "CMS is able to effectively structure and handle complex legal matters."
    Chambers Europe, 2024
  • Quote
    Their litigation abilities are excellent, with in-firm expertise available on related legal topics.
    The Legal500 EMEA, 2022
  • Quote
    Clients particularly value the team's commercial awareness, praising their "good insights into what is going on in the pharmaceutical market in the Netherlands."
    Chambers Europe, 2022
  • Quote
    The team is recommended for its "specific knowledge regarding tenders and projects in the field of medical appliances."
    Chambers Europe 2021
  • Quote
    The firm has "an excellent knowledge of pharmaceutical regulations and a practical mindset."
    Chambers Europe 2021
  • Quote
    ‘Speedy responses and practical advice in pharma and corporate law matters.’
    The Legal 500 EMEA, 2020
  • Quote
    "really brilliant" , "broad network" and that the firm "co-ordinates things well".
    Chambers Europe-wide, 2020
  • Quote
    "Really efficient and quick."
    Chambers Global, 2020
  • Quote
    "The firm is a reliable international firm that has shown us a deep knowledge of the applicable law and significant practical experience on relevant cases."
    Chambers Global, 2020

Life Sciences & Healthcare Insights

See all Insights
Legal Update Netherlands

How the EU Pharma Package will reshape orphan drug regulation

28 Jul 2026 8 min read
Expert Guide International

CMS Expert Guide to cannabis law and legislation

23 Jul 2026 7 min read
Expert Guide International

CMS Expert Guide to advertising of medicines and medical devices

22 Jul 2026 2 min read
Legal Update Netherlands

The extension of the Bolar exemption in the EU Pharma Package

21 Jul 2026 8 min read
Legal Update Netherlands

Stability as strategy: The UK’s regulatory position in the wake of the EU Pharmaceutical Package

15 Jul 2026 7 min read
Legal Update Netherlands

UK Clinical Trial Transparency and Patent Strategy

13 Jul 2026 12 min read
Legal Update Netherlands

T 655/24 - credibility test for improved technical effect applied to determine inventive step for a single amino acid change following G 2/21

02 Jul 2026 11 min read
Legal Update Netherlands

ICC Rules 2026: Key Reforms in Context

09 Jun 2026 11 min read

Events

Explore events
  • Netherlands
    08 Sep 2026

    2026 Insurance sector webinar programme

    Online
  • Netherlands
    10 Sep 2026

    IP Insights webinar series 2026 - Autumn

    Online
  • Netherlands
    30 Sep 2026

    On the Pulse Webinar Series 2026 - Autumn

    Online

Local market knowledge. Global outlook

We provide future-facing legal advice to help your organisation thrive. Combining local market knowledge and a global perspective, and with lawyers in locations worldwide, your organisation benefits from the expertise it needs, even across borders.

About CMS
People across CMS Find a Lawyer
10,000+ Staff
7,400+ Lawyers
Locations across CMS Find an office
50+ Countries
90+ Offices
22 Member firms
Back to top Back to top
If you want to use third party tools, please enable personalisation cookies as part of your cookie preferences. You can change this setting at any time via the button below or in our Cookie Notice.